These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
400 related items for PubMed ID: 27168264
1. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials. Stein Gold LF, Jarratt MT, Bucko AD, Grekin SK, Berlin JM, Bukhalo M, Weiss JS, Berk DR, Chang-Lin JE, Lin V, Kaoukhov A. J Drugs Dermatol; 2016 May 01; 15(5):553-61. PubMed ID: 27168264 [Abstract] [Full Text] [Related]
2. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials. Eichenfield LF, Lain T, Frankel EH, Jones TM, Chang-Lin JE, Berk DR, Ruan S, Kaoukhov A. J Drugs Dermatol; 2016 Aug 01; 15(8):962-9. PubMed ID: 27537997 [Abstract] [Full Text] [Related]
3. Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype. Taylor SC, Cook-Bolden FE, McMichael A, Downie JB, Rodriguez DA, Alexis AF, Callender VD, Alvandi N. J Drugs Dermatol; 2018 Feb 01; 17(2):160-167. PubMed ID: 29462223 [Abstract] [Full Text] [Related]
7. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population. Kircik LH, Baldwin H, Lain E, Guenin E, Harris S, Bhatt V. J Drugs Dermatol; 2019 Feb 01; 18(2):178-188. PubMed ID: 30811141 [Abstract] [Full Text] [Related]
10. Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris. Eichenfield LF, Gold LS, Nahm WK, Cook-Bolden FE, Pariser DM. J Drugs Dermatol; 2016 Dec 01; 15(12):1496-15027. PubMed ID: 28095573 [Abstract] [Full Text] [Related]
19. The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable. Tanghetti E, Harper JC, Oefelein MG. J Drugs Dermatol; 2012 Dec 01; 11(12):1417-21. PubMed ID: 23377510 [Abstract] [Full Text] [Related]
20. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability. Stein Gold L, Pariser DM, Guenin E. J Drugs Dermatol; 2019 Dec 01; 18(12):1218-1225. PubMed ID: 31860209 [Abstract] [Full Text] [Related] Page: [Next] [New Search]